Pets Anti-infective Drugs Industry Research Report 2023
Highlights
The global Pets Anti-infective Drugs market is projected to reach US$ million by 2029 from an estimated US$ million in 2023, at a CAGR of % during 2024 and 2029.
North American market for Pets Anti-infective Drugs is estimated to increase from $ million in 2022 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Pets Anti-infective Drugs is estimated to increase from $ million in 2022 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The major global manufacturers of Pets Anti-infective Drugs include Zoetis, Merck, Elanco, Virbac, Dechra Veterinary Products, Ceva Santй Animale, Vetoquinol, Nanjing Jindun Animal and Wuhan Chopperlvya, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
The global market for Pets Anti-infective Drugs in Dog is estimated to increase from $ million in 2022 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, External Use, which accounted for % of the global market of Pets Anti-infective Drugs in 2022, is expected to reach million US$ by 2029, growing at a revised CAGR of % from 2023 to 2029.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Pets Anti-infective Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pets Anti-infective Drugs.
The Pets Anti-infective Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Pets Anti-infective Drugs market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pets Anti-infective Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2018-2023. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
Global markets are presented by Pets Anti-infective Drugs type, along with growth forecasts through 2029. Estimates on sales and revenue are based on the price in the supply chain at which the Pets Anti-infective Drugs are procured by the manufacturers.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and during the historical period (2018-2023) and forecast period (2024-2029).
Pets Anti-infective Drugs segment by Administration Method
This report has provided the market size (sales and revenue data) by application, during the historical period (2018-2023) and forecast period (2024-2029).
This report also outlines the market trends of each segment and consumer behaviors impacting the Pets Anti-infective Drugs market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Pets Anti-infective Drugs market.
Pets Anti-infective Drugs segment by Application
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2018-2029.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2023 and forecast revenue for 2029.
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Pets Anti-infective Drugs market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pets Anti-infective Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Pets Anti-infective Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Pets Anti-infective Drugs industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pets Anti-infective Drugs.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Pets Anti-infective Drugs manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Pets Anti-infective Drugs by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Pets Anti-infective Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by administration method, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
The global Pets Anti-infective Drugs market is projected to reach US$ million by 2029 from an estimated US$ million in 2023, at a CAGR of % during 2024 and 2029.
North American market for Pets Anti-infective Drugs is estimated to increase from $ million in 2022 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Pets Anti-infective Drugs is estimated to increase from $ million in 2022 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The major global manufacturers of Pets Anti-infective Drugs include Zoetis, Merck, Elanco, Virbac, Dechra Veterinary Products, Ceva Santй Animale, Vetoquinol, Nanjing Jindun Animal and Wuhan Chopperlvya, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
The global market for Pets Anti-infective Drugs in Dog is estimated to increase from $ million in 2022 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, External Use, which accounted for % of the global market of Pets Anti-infective Drugs in 2022, is expected to reach million US$ by 2029, growing at a revised CAGR of % from 2023 to 2029.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Pets Anti-infective Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pets Anti-infective Drugs.
The Pets Anti-infective Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Pets Anti-infective Drugs market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pets Anti-infective Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2018-2023. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
- Zoetis
- Merck
- Elanco
- Virbac
- Dechra Veterinary Products
- Ceva Santй Animale
- Vetoquinol
- Nanjing Jindun Animal
- Wuhan Chopperlvya
- Bimeda Animal Health
- Ouro Fino Saude
- Norbrook
Global markets are presented by Pets Anti-infective Drugs type, along with growth forecasts through 2029. Estimates on sales and revenue are based on the price in the supply chain at which the Pets Anti-infective Drugs are procured by the manufacturers.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and during the historical period (2018-2023) and forecast period (2024-2029).
Pets Anti-infective Drugs segment by Administration Method
- External Use
- Internal Use
- Injection
This report has provided the market size (sales and revenue data) by application, during the historical period (2018-2023) and forecast period (2024-2029).
This report also outlines the market trends of each segment and consumer behaviors impacting the Pets Anti-infective Drugs market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Pets Anti-infective Drugs market.
Pets Anti-infective Drugs segment by Application
- Dog
- Cat
- Others
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2018-2029.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2023 and forecast revenue for 2029.
- North America
- United States
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Pets Anti-infective Drugs market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pets Anti-infective Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Pets Anti-infective Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Pets Anti-infective Drugs industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pets Anti-infective Drugs.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Pets Anti-infective Drugs manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Pets Anti-infective Drugs by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Pets Anti-infective Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by administration method, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
1 PREFACE
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 MARKET OVERVIEW
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Pets Anti-infective Drugs Market Size (2018-2029) & (US$ Million)
2.2.2 Global Pets Anti-infective Drugs Sales (2018-2029)
2.2.3 Global Pets Anti-infective Drugs Market Average Price (2018-2029)
2.3 Pets Anti-infective Drugs by Administration Method
2.3.1 Market Value Comparison by Administration Method (2018 VS 2022 VS 2029) & (US$ Million)
1.2.2 External Use
1.2.3 Internal Use
1.2.4 Injection
2.4 Pets Anti-infective Drugs by Application
2.4.1 Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
2.4.2 Dog
2.4.3 Cat
2.4.4 Others
3 MARKET COMPETITIVE LANDSCAPE BY MANUFACTURERS
3.1 Global Pets Anti-infective Drugs Market Competitive Situation by Manufacturers (2018 Versus 2022)
3.2 Global Pets Anti-infective Drugs Sales (K Units) of Manufacturers (2018-2023)
3.3 Global Pets Anti-infective Drugs Revenue of Manufacturers (2018-2023)
3.4 Global Pets Anti-infective Drugs Average Price by Manufacturers (2018-2023)
3.5 Global Pets Anti-infective Drugs Industry Ranking, 2021 VS 2022 VS 2023
3.6 Global Manufacturers of Pets Anti-infective Drugs, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Pets Anti-infective Drugs, Product Type & Application
3.8 Global Manufacturers of Pets Anti-infective Drugs, Date of Enter into This Industry
3.9 Global Pets Anti-infective Drugs Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 MANUFACTURERS PROFILED
4.1 Zoetis
4.1.1 Zoetis Company Information
4.1.2 Zoetis Business Overview
4.1.3 Zoetis Pets Anti-infective Drugs Sales, Revenue and Gross Margin (2018-2023)
4.1.4 Zoetis Pets Anti-infective Drugs Product Portfolio
4.1.5 Zoetis Recent Developments
4.2 Merck
4.2.1 Merck Company Information
4.2.2 Merck Business Overview
4.2.3 Merck Pets Anti-infective Drugs Sales, Revenue and Gross Margin (2018-2023)
4.2.4 Merck Pets Anti-infective Drugs Product Portfolio
4.2.5 Merck Recent Developments
4.3 Elanco
4.3.1 Elanco Company Information
4.3.2 Elanco Business Overview
4.3.3 Elanco Pets Anti-infective Drugs Sales, Revenue and Gross Margin (2018-2023)
4.3.4 Elanco Pets Anti-infective Drugs Product Portfolio
4.3.5 Elanco Recent Developments
4.4 Virbac
4.4.1 Virbac Company Information
4.4.2 Virbac Business Overview
4.4.3 Virbac Pets Anti-infective Drugs Sales, Revenue and Gross Margin (2018-2023)
4.4.4 Virbac Pets Anti-infective Drugs Product Portfolio
4.4.5 Virbac Recent Developments
4.5 Dechra Veterinary Products
4.5.1 Dechra Veterinary Products Company Information
4.5.2 Dechra Veterinary Products Business Overview
4.5.3 Dechra Veterinary Products Pets Anti-infective Drugs Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Dechra Veterinary Products Pets Anti-infective Drugs Product Portfolio
6.5.5 Dechra Veterinary Products Recent Developments
4.6 Ceva Santй Animale
4.6.1 Ceva Santй Animale Company Information
4.6.2 Ceva Santй Animale Business Overview
4.6.3 Ceva Santй Animale Pets Anti-infective Drugs Sales, Revenue and Gross Margin (2018-2023)
4.6.4 Ceva Santй Animale Pets Anti-infective Drugs Product Portfolio
4.6.5 Ceva Santй Animale Recent Developments
4.7 Vetoquinol
4.7.1 Vetoquinol Company Information
4.7.2 Vetoquinol Business Overview
4.7.3 Vetoquinol Pets Anti-infective Drugs Sales, Revenue and Gross Margin (2018-2023)
4.7.4 Vetoquinol Pets Anti-infective Drugs Product Portfolio
4.7.5 Vetoquinol Recent Developments
6.8 Nanjing Jindun Animal
4.8.1 Nanjing Jindun Animal Company Information
4.8.2 Nanjing Jindun Animal Business Overview
4.8.3 Nanjing Jindun Animal Pets Anti-infective Drugs Sales, Revenue and Gross Margin (2018-2023)
4.8.4 Nanjing Jindun Animal Pets Anti-infective Drugs Product Portfolio
4.8.5 Nanjing Jindun Animal Recent Developments
4.9 Wuhan Chopperlvya
4.9.1 Wuhan Chopperlvya Company Information
4.9.2 Wuhan Chopperlvya Business Overview
4.9.3 Wuhan Chopperlvya Pets Anti-infective Drugs Sales, Revenue and Gross Margin (2018-2023)
4.9.4 Wuhan Chopperlvya Pets Anti-infective Drugs Product Portfolio
4.9.5 Wuhan Chopperlvya Recent Developments
4.10 Bimeda Animal Health
4.10.1 Bimeda Animal Health Company Information
4.10.2 Bimeda Animal Health Business Overview
4.10.3 Bimeda Animal Health Pets Anti-infective Drugs Sales, Revenue and Gross Margin (2018-2023)
4.10.4 Bimeda Animal Health Pets Anti-infective Drugs Product Portfolio
4.10.5 Bimeda Animal Health Recent Developments
6.11 Ouro Fino Saude
6.11.1 Ouro Fino Saude Company Information
6.11.2 Ouro Fino Saude Pets Anti-infective Drugs Business Overview
6.11.3 Ouro Fino Saude Pets Anti-infective Drugs Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Ouro Fino Saude Pets Anti-infective Drugs Product Portfolio
6.11.5 Ouro Fino Saude Recent Developments
6.12 Norbrook
6.12.1 Norbrook Company Information
6.12.2 Norbrook Pets Anti-infective Drugs Business Overview
6.12.3 Norbrook Pets Anti-infective Drugs Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Norbrook Pets Anti-infective Drugs Product Portfolio
6.12.5 Norbrook Recent Developments
5 GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SCENARIO BY REGION
5.1 Global Pets Anti-infective Drugs Market Size by Region: 2018 VS 2022 VS 2029
5.2 Global Pets Anti-infective Drugs Sales by Region: 2018-2029
5.2.1 Global Pets Anti-infective Drugs Sales by Region: 2018-2023
5.2.2 Global Pets Anti-infective Drugs Sales by Region: 2024-2029
5.3 Global Pets Anti-infective Drugs Revenue by Region: 2018-2029
5.3.1 Global Pets Anti-infective Drugs Revenue by Region: 2018-2023
5.3.2 Global Pets Anti-infective Drugs Revenue by Region: 2024-2029
5.4 North America Pets Anti-infective Drugs Market Facts & Figures by Country
5.4.1 North America Pets Anti-infective Drugs Market Size by Country: 2018 VS 2022 VS 2029
5.4.2 North America Pets Anti-infective Drugs Sales by Country (2018-2029)
5.4.3 North America Pets Anti-infective Drugs Revenue by Country (2018-2029)
5.4.4 United States
5.4.5 Canada
5.5 Europe Pets Anti-infective Drugs Market Facts & Figures by Country
5.5.1 Europe Pets Anti-infective Drugs Market Size by Country: 2018 VS 2022 VS 2029
5.5.2 Europe Pets Anti-infective Drugs Sales by Country (2018-2029)
5.5.3 Europe Pets Anti-infective Drugs Revenue by Country (2018-2029)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Russia
5.6 Asia Pacific Pets Anti-infective Drugs Market Facts & Figures by Country
5.6.1 Asia Pacific Pets Anti-infective Drugs Market Size by Country: 2018 VS 2022 VS 2029
5.6.2 Asia Pacific Pets Anti-infective Drugs Sales by Country (2018-2029)
5.6.3 Asia Pacific Pets Anti-infective Drugs Revenue by Country (2018-2029)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 China Taiwan
5.6.10 Indonesia
5.6.11 Thailand
5.6.12 Malaysia
5.7 Latin America Pets Anti-infective Drugs Market Facts & Figures by Country
5.7.1 Latin America Pets Anti-infective Drugs Market Size by Country: 2018 VS 2022 VS 2029
5.7.2 Latin America Pets Anti-infective Drugs Sales by Country (2018-2029)
5.7.3 Latin America Pets Anti-infective Drugs Revenue by Country (2018-2029)
5.7.4 Mexico
5.7.5 Brazil
5.7.6 Argentina
5.8 Middle East and Africa Pets Anti-infective Drugs Market Facts & Figures by Country
5.8.1 Middle East and Africa Pets Anti-infective Drugs Market Size by Country: 2018 VS 2022 VS 2029
5.8.2 Middle East and Africa Pets Anti-infective Drugs Sales by Country (2018-2029)
5.8.3 Middle East and Africa Pets Anti-infective Drugs Revenue by Country (2018-2029)
5.8.4 Turkey
5.8.5 Saudi Arabia
5.8.6 UAE
6 SEGMENT BY ADMINISTRATION METHOD
6.1 Global Pets Anti-infective Drugs Sales by Administration Method (2018-2029)
6.1.1 Global Pets Anti-infective Drugs Sales by Administration Method (2018-2029) & (K Units)
6.1.2 Global Pets Anti-infective Drugs Sales Market Share by Administration Method (2018-2029)
6.2 Global Pets Anti-infective Drugs Revenue by Administration Method (2018-2029)
6.2.1 Global Pets Anti-infective Drugs Sales by Administration Method (2018-2029) & (US$ Million)
6.2.2 Global Pets Anti-infective Drugs Revenue Market Share by Administration Method (2018-2029)
6.3 Global Pets Anti-infective Drugs Price by Administration Method (2018-2029)
7 SEGMENT BY APPLICATION
7.1 Global Pets Anti-infective Drugs Sales by Application (2018-2029)
7.1.1 Global Pets Anti-infective Drugs Sales by Application (2018-2029) & (K Units)
7.1.2 Global Pets Anti-infective Drugs Sales Market Share by Application (2018-2029)
7.2 Global Pets Anti-infective Drugs Revenue by Application (2018-2029)
6.2.1 Global Pets Anti-infective Drugs Sales by Application (2018-2029) & (US$ Million)
6.2.2 Global Pets Anti-infective Drugs Revenue Market Share by Application (2018-2029)
7.3 Global Pets Anti-infective Drugs Price by Application (2018-2029)
8 VALUE CHAIN AND SALES CHANNELS ANALYSIS OF THE MARKET
8.1 Pets Anti-infective Drugs Value Chain Analysis
8.1.1 Pets Anti-infective Drugs Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Pets Anti-infective Drugs Production Mode & Process
8.2 Pets Anti-infective Drugs Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Pets Anti-infective Drugs Distributors
8.2.3 Pets Anti-infective Drugs Customers
9 GLOBAL PETS ANTI-INFECTIVE DRUGS ANALYZING MARKET DYNAMICS
9.1 Pets Anti-infective Drugs Industry Trends
9.2 Pets Anti-infective Drugs Industry Drivers
9.3 Pets Anti-infective Drugs Industry Opportunities and Challenges
9.4 Pets Anti-infective Drugs Industry Restraints
10 REPORT CONCLUSION
11 DISCLAIMER
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 MARKET OVERVIEW
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Pets Anti-infective Drugs Market Size (2018-2029) & (US$ Million)
2.2.2 Global Pets Anti-infective Drugs Sales (2018-2029)
2.2.3 Global Pets Anti-infective Drugs Market Average Price (2018-2029)
2.3 Pets Anti-infective Drugs by Administration Method
2.3.1 Market Value Comparison by Administration Method (2018 VS 2022 VS 2029) & (US$ Million)
1.2.2 External Use
1.2.3 Internal Use
1.2.4 Injection
2.4 Pets Anti-infective Drugs by Application
2.4.1 Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
2.4.2 Dog
2.4.3 Cat
2.4.4 Others
3 MARKET COMPETITIVE LANDSCAPE BY MANUFACTURERS
3.1 Global Pets Anti-infective Drugs Market Competitive Situation by Manufacturers (2018 Versus 2022)
3.2 Global Pets Anti-infective Drugs Sales (K Units) of Manufacturers (2018-2023)
3.3 Global Pets Anti-infective Drugs Revenue of Manufacturers (2018-2023)
3.4 Global Pets Anti-infective Drugs Average Price by Manufacturers (2018-2023)
3.5 Global Pets Anti-infective Drugs Industry Ranking, 2021 VS 2022 VS 2023
3.6 Global Manufacturers of Pets Anti-infective Drugs, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Pets Anti-infective Drugs, Product Type & Application
3.8 Global Manufacturers of Pets Anti-infective Drugs, Date of Enter into This Industry
3.9 Global Pets Anti-infective Drugs Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 MANUFACTURERS PROFILED
4.1 Zoetis
4.1.1 Zoetis Company Information
4.1.2 Zoetis Business Overview
4.1.3 Zoetis Pets Anti-infective Drugs Sales, Revenue and Gross Margin (2018-2023)
4.1.4 Zoetis Pets Anti-infective Drugs Product Portfolio
4.1.5 Zoetis Recent Developments
4.2 Merck
4.2.1 Merck Company Information
4.2.2 Merck Business Overview
4.2.3 Merck Pets Anti-infective Drugs Sales, Revenue and Gross Margin (2018-2023)
4.2.4 Merck Pets Anti-infective Drugs Product Portfolio
4.2.5 Merck Recent Developments
4.3 Elanco
4.3.1 Elanco Company Information
4.3.2 Elanco Business Overview
4.3.3 Elanco Pets Anti-infective Drugs Sales, Revenue and Gross Margin (2018-2023)
4.3.4 Elanco Pets Anti-infective Drugs Product Portfolio
4.3.5 Elanco Recent Developments
4.4 Virbac
4.4.1 Virbac Company Information
4.4.2 Virbac Business Overview
4.4.3 Virbac Pets Anti-infective Drugs Sales, Revenue and Gross Margin (2018-2023)
4.4.4 Virbac Pets Anti-infective Drugs Product Portfolio
4.4.5 Virbac Recent Developments
4.5 Dechra Veterinary Products
4.5.1 Dechra Veterinary Products Company Information
4.5.2 Dechra Veterinary Products Business Overview
4.5.3 Dechra Veterinary Products Pets Anti-infective Drugs Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Dechra Veterinary Products Pets Anti-infective Drugs Product Portfolio
6.5.5 Dechra Veterinary Products Recent Developments
4.6 Ceva Santй Animale
4.6.1 Ceva Santй Animale Company Information
4.6.2 Ceva Santй Animale Business Overview
4.6.3 Ceva Santй Animale Pets Anti-infective Drugs Sales, Revenue and Gross Margin (2018-2023)
4.6.4 Ceva Santй Animale Pets Anti-infective Drugs Product Portfolio
4.6.5 Ceva Santй Animale Recent Developments
4.7 Vetoquinol
4.7.1 Vetoquinol Company Information
4.7.2 Vetoquinol Business Overview
4.7.3 Vetoquinol Pets Anti-infective Drugs Sales, Revenue and Gross Margin (2018-2023)
4.7.4 Vetoquinol Pets Anti-infective Drugs Product Portfolio
4.7.5 Vetoquinol Recent Developments
6.8 Nanjing Jindun Animal
4.8.1 Nanjing Jindun Animal Company Information
4.8.2 Nanjing Jindun Animal Business Overview
4.8.3 Nanjing Jindun Animal Pets Anti-infective Drugs Sales, Revenue and Gross Margin (2018-2023)
4.8.4 Nanjing Jindun Animal Pets Anti-infective Drugs Product Portfolio
4.8.5 Nanjing Jindun Animal Recent Developments
4.9 Wuhan Chopperlvya
4.9.1 Wuhan Chopperlvya Company Information
4.9.2 Wuhan Chopperlvya Business Overview
4.9.3 Wuhan Chopperlvya Pets Anti-infective Drugs Sales, Revenue and Gross Margin (2018-2023)
4.9.4 Wuhan Chopperlvya Pets Anti-infective Drugs Product Portfolio
4.9.5 Wuhan Chopperlvya Recent Developments
4.10 Bimeda Animal Health
4.10.1 Bimeda Animal Health Company Information
4.10.2 Bimeda Animal Health Business Overview
4.10.3 Bimeda Animal Health Pets Anti-infective Drugs Sales, Revenue and Gross Margin (2018-2023)
4.10.4 Bimeda Animal Health Pets Anti-infective Drugs Product Portfolio
4.10.5 Bimeda Animal Health Recent Developments
6.11 Ouro Fino Saude
6.11.1 Ouro Fino Saude Company Information
6.11.2 Ouro Fino Saude Pets Anti-infective Drugs Business Overview
6.11.3 Ouro Fino Saude Pets Anti-infective Drugs Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Ouro Fino Saude Pets Anti-infective Drugs Product Portfolio
6.11.5 Ouro Fino Saude Recent Developments
6.12 Norbrook
6.12.1 Norbrook Company Information
6.12.2 Norbrook Pets Anti-infective Drugs Business Overview
6.12.3 Norbrook Pets Anti-infective Drugs Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Norbrook Pets Anti-infective Drugs Product Portfolio
6.12.5 Norbrook Recent Developments
5 GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SCENARIO BY REGION
5.1 Global Pets Anti-infective Drugs Market Size by Region: 2018 VS 2022 VS 2029
5.2 Global Pets Anti-infective Drugs Sales by Region: 2018-2029
5.2.1 Global Pets Anti-infective Drugs Sales by Region: 2018-2023
5.2.2 Global Pets Anti-infective Drugs Sales by Region: 2024-2029
5.3 Global Pets Anti-infective Drugs Revenue by Region: 2018-2029
5.3.1 Global Pets Anti-infective Drugs Revenue by Region: 2018-2023
5.3.2 Global Pets Anti-infective Drugs Revenue by Region: 2024-2029
5.4 North America Pets Anti-infective Drugs Market Facts & Figures by Country
5.4.1 North America Pets Anti-infective Drugs Market Size by Country: 2018 VS 2022 VS 2029
5.4.2 North America Pets Anti-infective Drugs Sales by Country (2018-2029)
5.4.3 North America Pets Anti-infective Drugs Revenue by Country (2018-2029)
5.4.4 United States
5.4.5 Canada
5.5 Europe Pets Anti-infective Drugs Market Facts & Figures by Country
5.5.1 Europe Pets Anti-infective Drugs Market Size by Country: 2018 VS 2022 VS 2029
5.5.2 Europe Pets Anti-infective Drugs Sales by Country (2018-2029)
5.5.3 Europe Pets Anti-infective Drugs Revenue by Country (2018-2029)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Russia
5.6 Asia Pacific Pets Anti-infective Drugs Market Facts & Figures by Country
5.6.1 Asia Pacific Pets Anti-infective Drugs Market Size by Country: 2018 VS 2022 VS 2029
5.6.2 Asia Pacific Pets Anti-infective Drugs Sales by Country (2018-2029)
5.6.3 Asia Pacific Pets Anti-infective Drugs Revenue by Country (2018-2029)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 China Taiwan
5.6.10 Indonesia
5.6.11 Thailand
5.6.12 Malaysia
5.7 Latin America Pets Anti-infective Drugs Market Facts & Figures by Country
5.7.1 Latin America Pets Anti-infective Drugs Market Size by Country: 2018 VS 2022 VS 2029
5.7.2 Latin America Pets Anti-infective Drugs Sales by Country (2018-2029)
5.7.3 Latin America Pets Anti-infective Drugs Revenue by Country (2018-2029)
5.7.4 Mexico
5.7.5 Brazil
5.7.6 Argentina
5.8 Middle East and Africa Pets Anti-infective Drugs Market Facts & Figures by Country
5.8.1 Middle East and Africa Pets Anti-infective Drugs Market Size by Country: 2018 VS 2022 VS 2029
5.8.2 Middle East and Africa Pets Anti-infective Drugs Sales by Country (2018-2029)
5.8.3 Middle East and Africa Pets Anti-infective Drugs Revenue by Country (2018-2029)
5.8.4 Turkey
5.8.5 Saudi Arabia
5.8.6 UAE
6 SEGMENT BY ADMINISTRATION METHOD
6.1 Global Pets Anti-infective Drugs Sales by Administration Method (2018-2029)
6.1.1 Global Pets Anti-infective Drugs Sales by Administration Method (2018-2029) & (K Units)
6.1.2 Global Pets Anti-infective Drugs Sales Market Share by Administration Method (2018-2029)
6.2 Global Pets Anti-infective Drugs Revenue by Administration Method (2018-2029)
6.2.1 Global Pets Anti-infective Drugs Sales by Administration Method (2018-2029) & (US$ Million)
6.2.2 Global Pets Anti-infective Drugs Revenue Market Share by Administration Method (2018-2029)
6.3 Global Pets Anti-infective Drugs Price by Administration Method (2018-2029)
7 SEGMENT BY APPLICATION
7.1 Global Pets Anti-infective Drugs Sales by Application (2018-2029)
7.1.1 Global Pets Anti-infective Drugs Sales by Application (2018-2029) & (K Units)
7.1.2 Global Pets Anti-infective Drugs Sales Market Share by Application (2018-2029)
7.2 Global Pets Anti-infective Drugs Revenue by Application (2018-2029)
6.2.1 Global Pets Anti-infective Drugs Sales by Application (2018-2029) & (US$ Million)
6.2.2 Global Pets Anti-infective Drugs Revenue Market Share by Application (2018-2029)
7.3 Global Pets Anti-infective Drugs Price by Application (2018-2029)
8 VALUE CHAIN AND SALES CHANNELS ANALYSIS OF THE MARKET
8.1 Pets Anti-infective Drugs Value Chain Analysis
8.1.1 Pets Anti-infective Drugs Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Pets Anti-infective Drugs Production Mode & Process
8.2 Pets Anti-infective Drugs Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Pets Anti-infective Drugs Distributors
8.2.3 Pets Anti-infective Drugs Customers
9 GLOBAL PETS ANTI-INFECTIVE DRUGS ANALYZING MARKET DYNAMICS
9.1 Pets Anti-infective Drugs Industry Trends
9.2 Pets Anti-infective Drugs Industry Drivers
9.3 Pets Anti-infective Drugs Industry Opportunities and Challenges
9.4 Pets Anti-infective Drugs Industry Restraints
10 REPORT CONCLUSION
11 DISCLAIMER
LIST OF TABLES
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Administration Method (2018 VS 2022 VS 2029) & (US$ Million)
Table 4. Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
Table 5. Global Pets Anti-infective Drugs Volume and Revenue Market Size and CAGR of Manufacturers (2018 Versus 2022)
Table 6. Global Pets Anti-infective Drugs Sales (K Units) of Manufacturers (2018-2023)
Table 7. Global Pets Anti-infective Drugs Sales Market Share by Manufacturers (2018-2023)
Table 8. Global Pets Anti-infective Drugs Revenue of Manufacturers (2018-2023)
Table 9. Global Pets Anti-infective Drugs Revenue Share by Manufacturers (2018-2023)
Table 10. Global Market Pets Anti-infective Drugs Average Price (US$/Unit) of Manufacturers (2018-2023)
Table 11. Global Pets Anti-infective Drugs Industry Ranking, 2021 VS 2022 VS 2023
Table 12. Global Manufacturers of Pets Anti-infective Drugs, Product Type & Application
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Pets Anti-infective Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans)
Table 16. Zoetis Company Information
Table 17. Zoetis Business Overview
Table 18. Zoetis Pets Anti-infective Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 19. Zoetis Pets Anti-infective Drugs Product Portfolio
Table 20. Zoetis Recent Developments
Table 21. Merck Company Information
Table 22. Merck Business Overview
Table 23. Merck Pets Anti-infective Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 24. Merck Pets Anti-infective Drugs Product Portfolio
Table 25. Merck Recent Developments
Table 26. Elanco Company Information
Table 27. Elanco Business Overview
Table 28. Elanco Pets Anti-infective Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 29. Elanco Pets Anti-infective Drugs Product Portfolio
Table 30. Elanco Recent Developments
Table 31. Virbac Company Information
Table 32. Virbac Business Overview
Table 33. Virbac Pets Anti-infective Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 34. Virbac Pets Anti-infective Drugs Product Portfolio
Table 35. Virbac Recent Developments
Table 36. Dechra Veterinary Products Company Information
Table 37. Dechra Veterinary Products Business Overview
Table 38. Dechra Veterinary Products Pets Anti-infective Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 39. Dechra Veterinary Products Pets Anti-infective Drugs Product Portfolio
Table 40. Dechra Veterinary Products Recent Developments
Table 41. Ceva Santй Animale Company Information
Table 42. Ceva Santй Animale Business Overview
Table 43. Ceva Santй Animale Pets Anti-infective Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 44. Ceva Santй Animale Pets Anti-infective Drugs Product Portfolio
Table 45. Ceva Santй Animale Recent Developments
Table 46. Vetoquinol Company Information
Table 47. Vetoquinol Business Overview
Table 48. Vetoquinol Pets Anti-infective Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 49. Vetoquinol Pets Anti-infective Drugs Product Portfolio
Table 50. Vetoquinol Recent Developments
Table 51. Nanjing Jindun Animal Company Information
Table 52. Nanjing Jindun Animal Business Overview
Table 53. Nanjing Jindun Animal Pets Anti-infective Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 54. Nanjing Jindun Animal Pets Anti-infective Drugs Product Portfolio
Table 55. Nanjing Jindun Animal Recent Developments
Table 56. Wuhan Chopperlvya Company Information
Table 57. Wuhan Chopperlvya Business Overview
Table 58. Wuhan Chopperlvya Pets Anti-infective Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 59. Wuhan Chopperlvya Pets Anti-infective Drugs Product Portfolio
Table 60. Wuhan Chopperlvya Recent Developments
Table 61. Bimeda Animal Health Company Information
Table 62. Bimeda Animal Health Business Overview
Table 63. Bimeda Animal Health Pets Anti-infective Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 64. Bimeda Animal Health Pets Anti-infective Drugs Product Portfolio
Table 65. Bimeda Animal Health Recent Developments
Table 66. Ouro Fino Saude Company Information
Table 67. Ouro Fino Saude Business Overview
Table 68. Ouro Fino Saude Pets Anti-infective Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 69. Ouro Fino Saude Pets Anti-infective Drugs Product Portfolio
Table 70. Ouro Fino Saude Recent Developments
Table 71. Norbrook Company Information
Table 72. Norbrook Business Overview
Table 73. Norbrook Pets Anti-infective Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 74. Norbrook Pets Anti-infective Drugs Product Portfolio
Table 75. Norbrook Recent Developments
Table 76. Global Pets Anti-infective Drugs Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 77. Global Pets Anti-infective Drugs Sales by Region (2018-2023) & (K Units)
Table 78. Global Pets Anti-infective Drugs Sales Market Share by Region (2018-2023)
Table 79. Global Pets Anti-infective Drugs Sales by Region (2024-2029) & (K Units)
Table 80. Global Pets Anti-infective Drugs Sales Market Share by Region (2024-2029)
Table 81. Global Pets Anti-infective Drugs Revenue by Region (2018-2023) & (US$ Million)
Table 82. Global Pets Anti-infective Drugs Revenue Market Share by Region (2018-2023)
Table 83. Global Pets Anti-infective Drugs Revenue by Region (2024-2029) & (US$ Million)
Table 84. Global Pets Anti-infective Drugs Revenue Market Share by Region (2024-2029)
Table 85. North America Pets Anti-infective Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 86. North America Pets Anti-infective Drugs Sales by Country (2018-2023) & (K Units)
Table 87. North America Pets Anti-infective Drugs Sales by Country (2024-2029) & (K Units)
Table 88. North America Pets Anti-infective Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 89. North America Pets Anti-infective Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 90. Europe Pets Anti-infective Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 91. Europe Pets Anti-infective Drugs Sales by Country (2018-2023) & (K Units)
Table 92. Europe Pets Anti-infective Drugs Sales by Country (2024-2029) & (K Units)
Table 93. Europe Pets Anti-infective Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 94. Europe Pets Anti-infective Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 95. Asia Pacific Pets Anti-infective Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 96. Asia Pacific Pets Anti-infective Drugs Sales by Country (2018-2023) & (K Units)
Table 97. Asia Pacific Pets Anti-infective Drugs Sales by Country (2024-2029) & (K Units)
Table 98. Asia Pacific Pets Anti-infective Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 99. Asia Pacific Pets Anti-infective Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 100. Latin America Pets Anti-infective Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 101. Latin America Pets Anti-infective Drugs Sales by Country (2018-2023) & (K Units)
Table 102. Latin America Pets Anti-infective Drugs Sales by Country (2024-2029) & (K Units)
Table 103. Latin America Pets Anti-infective Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 104. Latin America Pets Anti-infective Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 105. Middle East and Africa Pets Anti-infective Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 106. Middle East and Africa Pets Anti-infective Drugs Sales by Country (2018-2023) & (K Units)
Table 107. Middle East and Africa Pets Anti-infective Drugs Sales by Country (2024-2029) & (K Units)
Table 108. Middle East and Africa Pets Anti-infective Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 109. Middle East and Africa Pets Anti-infective Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 110. Global Pets Anti-infective Drugs Sales by Administration Method (2018-2023) & (K Units)
Table 111. Global Pets Anti-infective Drugs Sales by Administration Method (2024-2029) & (K Units)
Table 112. Global Pets Anti-infective Drugs Sales Market Share by Administration Method (2018-2023)
Table 113. Global Pets Anti-infective Drugs Sales Market Share by Administration Method (2024-2029)
Table 114. Global Pets Anti-infective Drugs Revenue by Administration Method (2018-2023) & (US$ Million)
Table 115. Global Pets Anti-infective Drugs Revenue by Administration Method (2024-2029) & (US$ Million)
Table 116. Global Pets Anti-infective Drugs Revenue Market Share by Administration Method (2018-2023)
Table 117. Global Pets Anti-infective Drugs Revenue Market Share by Administration Method (2024-2029)
Table 118. Global Pets Anti-infective Drugs Price by Administration Method (2018-2023) & (US$/Unit)
Table 119. Global Pets Anti-infective Drugs Price by Administration Method (2024-2029) & (US$/Unit)
Table 120. Global Pets Anti-infective Drugs Sales by Application (2018-2023) & (K Units)
Table 121. Global Pets Anti-infective Drugs Sales by Application (2024-2029) & (K Units)
Table 122. Global Pets Anti-infective Drugs Sales Market Share by Application (2018-2023)
Table 123. Global Pets Anti-infective Drugs Sales Market Share by Application (2024-2029)
Table 124. Global Pets Anti-infective Drugs Revenue by Application (2018-2023) & (US$ Million)
Table 125. Global Pets Anti-infective Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 126. Global Pets Anti-infective Drugs Revenue Market Share by Application (2018-2023)
Table 127. Global Pets Anti-infective Drugs Revenue Market Share by Application (2024-2029)
Table 128. Global Pets Anti-infective Drugs Price by Application (2018-2023) & (US$/Unit)
Table 129. Global Pets Anti-infective Drugs Price by Application (2024-2029) & (US$/Unit)
Table 130. Key Raw Materials
Table 131. Raw Materials Key Suppliers
Table 132. Pets Anti-infective Drugs Distributors List
Table 133. Pets Anti-infective Drugs Customers List
Table 134. Pets Anti-infective Drugs Industry Trends
Table 135. Pets Anti-infective Drugs Industry Drivers
Table 136. Pets Anti-infective Drugs Industry Restraints
Table 137. Authors List of This Report
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Administration Method (2018 VS 2022 VS 2029) & (US$ Million)
Table 4. Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
Table 5. Global Pets Anti-infective Drugs Volume and Revenue Market Size and CAGR of Manufacturers (2018 Versus 2022)
Table 6. Global Pets Anti-infective Drugs Sales (K Units) of Manufacturers (2018-2023)
Table 7. Global Pets Anti-infective Drugs Sales Market Share by Manufacturers (2018-2023)
Table 8. Global Pets Anti-infective Drugs Revenue of Manufacturers (2018-2023)
Table 9. Global Pets Anti-infective Drugs Revenue Share by Manufacturers (2018-2023)
Table 10. Global Market Pets Anti-infective Drugs Average Price (US$/Unit) of Manufacturers (2018-2023)
Table 11. Global Pets Anti-infective Drugs Industry Ranking, 2021 VS 2022 VS 2023
Table 12. Global Manufacturers of Pets Anti-infective Drugs, Product Type & Application
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Pets Anti-infective Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans)
Table 16. Zoetis Company Information
Table 17. Zoetis Business Overview
Table 18. Zoetis Pets Anti-infective Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 19. Zoetis Pets Anti-infective Drugs Product Portfolio
Table 20. Zoetis Recent Developments
Table 21. Merck Company Information
Table 22. Merck Business Overview
Table 23. Merck Pets Anti-infective Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 24. Merck Pets Anti-infective Drugs Product Portfolio
Table 25. Merck Recent Developments
Table 26. Elanco Company Information
Table 27. Elanco Business Overview
Table 28. Elanco Pets Anti-infective Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 29. Elanco Pets Anti-infective Drugs Product Portfolio
Table 30. Elanco Recent Developments
Table 31. Virbac Company Information
Table 32. Virbac Business Overview
Table 33. Virbac Pets Anti-infective Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 34. Virbac Pets Anti-infective Drugs Product Portfolio
Table 35. Virbac Recent Developments
Table 36. Dechra Veterinary Products Company Information
Table 37. Dechra Veterinary Products Business Overview
Table 38. Dechra Veterinary Products Pets Anti-infective Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 39. Dechra Veterinary Products Pets Anti-infective Drugs Product Portfolio
Table 40. Dechra Veterinary Products Recent Developments
Table 41. Ceva Santй Animale Company Information
Table 42. Ceva Santй Animale Business Overview
Table 43. Ceva Santй Animale Pets Anti-infective Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 44. Ceva Santй Animale Pets Anti-infective Drugs Product Portfolio
Table 45. Ceva Santй Animale Recent Developments
Table 46. Vetoquinol Company Information
Table 47. Vetoquinol Business Overview
Table 48. Vetoquinol Pets Anti-infective Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 49. Vetoquinol Pets Anti-infective Drugs Product Portfolio
Table 50. Vetoquinol Recent Developments
Table 51. Nanjing Jindun Animal Company Information
Table 52. Nanjing Jindun Animal Business Overview
Table 53. Nanjing Jindun Animal Pets Anti-infective Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 54. Nanjing Jindun Animal Pets Anti-infective Drugs Product Portfolio
Table 55. Nanjing Jindun Animal Recent Developments
Table 56. Wuhan Chopperlvya Company Information
Table 57. Wuhan Chopperlvya Business Overview
Table 58. Wuhan Chopperlvya Pets Anti-infective Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 59. Wuhan Chopperlvya Pets Anti-infective Drugs Product Portfolio
Table 60. Wuhan Chopperlvya Recent Developments
Table 61. Bimeda Animal Health Company Information
Table 62. Bimeda Animal Health Business Overview
Table 63. Bimeda Animal Health Pets Anti-infective Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 64. Bimeda Animal Health Pets Anti-infective Drugs Product Portfolio
Table 65. Bimeda Animal Health Recent Developments
Table 66. Ouro Fino Saude Company Information
Table 67. Ouro Fino Saude Business Overview
Table 68. Ouro Fino Saude Pets Anti-infective Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 69. Ouro Fino Saude Pets Anti-infective Drugs Product Portfolio
Table 70. Ouro Fino Saude Recent Developments
Table 71. Norbrook Company Information
Table 72. Norbrook Business Overview
Table 73. Norbrook Pets Anti-infective Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 74. Norbrook Pets Anti-infective Drugs Product Portfolio
Table 75. Norbrook Recent Developments
Table 76. Global Pets Anti-infective Drugs Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 77. Global Pets Anti-infective Drugs Sales by Region (2018-2023) & (K Units)
Table 78. Global Pets Anti-infective Drugs Sales Market Share by Region (2018-2023)
Table 79. Global Pets Anti-infective Drugs Sales by Region (2024-2029) & (K Units)
Table 80. Global Pets Anti-infective Drugs Sales Market Share by Region (2024-2029)
Table 81. Global Pets Anti-infective Drugs Revenue by Region (2018-2023) & (US$ Million)
Table 82. Global Pets Anti-infective Drugs Revenue Market Share by Region (2018-2023)
Table 83. Global Pets Anti-infective Drugs Revenue by Region (2024-2029) & (US$ Million)
Table 84. Global Pets Anti-infective Drugs Revenue Market Share by Region (2024-2029)
Table 85. North America Pets Anti-infective Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 86. North America Pets Anti-infective Drugs Sales by Country (2018-2023) & (K Units)
Table 87. North America Pets Anti-infective Drugs Sales by Country (2024-2029) & (K Units)
Table 88. North America Pets Anti-infective Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 89. North America Pets Anti-infective Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 90. Europe Pets Anti-infective Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 91. Europe Pets Anti-infective Drugs Sales by Country (2018-2023) & (K Units)
Table 92. Europe Pets Anti-infective Drugs Sales by Country (2024-2029) & (K Units)
Table 93. Europe Pets Anti-infective Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 94. Europe Pets Anti-infective Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 95. Asia Pacific Pets Anti-infective Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 96. Asia Pacific Pets Anti-infective Drugs Sales by Country (2018-2023) & (K Units)
Table 97. Asia Pacific Pets Anti-infective Drugs Sales by Country (2024-2029) & (K Units)
Table 98. Asia Pacific Pets Anti-infective Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 99. Asia Pacific Pets Anti-infective Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 100. Latin America Pets Anti-infective Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 101. Latin America Pets Anti-infective Drugs Sales by Country (2018-2023) & (K Units)
Table 102. Latin America Pets Anti-infective Drugs Sales by Country (2024-2029) & (K Units)
Table 103. Latin America Pets Anti-infective Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 104. Latin America Pets Anti-infective Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 105. Middle East and Africa Pets Anti-infective Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 106. Middle East and Africa Pets Anti-infective Drugs Sales by Country (2018-2023) & (K Units)
Table 107. Middle East and Africa Pets Anti-infective Drugs Sales by Country (2024-2029) & (K Units)
Table 108. Middle East and Africa Pets Anti-infective Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 109. Middle East and Africa Pets Anti-infective Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 110. Global Pets Anti-infective Drugs Sales by Administration Method (2018-2023) & (K Units)
Table 111. Global Pets Anti-infective Drugs Sales by Administration Method (2024-2029) & (K Units)
Table 112. Global Pets Anti-infective Drugs Sales Market Share by Administration Method (2018-2023)
Table 113. Global Pets Anti-infective Drugs Sales Market Share by Administration Method (2024-2029)
Table 114. Global Pets Anti-infective Drugs Revenue by Administration Method (2018-2023) & (US$ Million)
Table 115. Global Pets Anti-infective Drugs Revenue by Administration Method (2024-2029) & (US$ Million)
Table 116. Global Pets Anti-infective Drugs Revenue Market Share by Administration Method (2018-2023)
Table 117. Global Pets Anti-infective Drugs Revenue Market Share by Administration Method (2024-2029)
Table 118. Global Pets Anti-infective Drugs Price by Administration Method (2018-2023) & (US$/Unit)
Table 119. Global Pets Anti-infective Drugs Price by Administration Method (2024-2029) & (US$/Unit)
Table 120. Global Pets Anti-infective Drugs Sales by Application (2018-2023) & (K Units)
Table 121. Global Pets Anti-infective Drugs Sales by Application (2024-2029) & (K Units)
Table 122. Global Pets Anti-infective Drugs Sales Market Share by Application (2018-2023)
Table 123. Global Pets Anti-infective Drugs Sales Market Share by Application (2024-2029)
Table 124. Global Pets Anti-infective Drugs Revenue by Application (2018-2023) & (US$ Million)
Table 125. Global Pets Anti-infective Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 126. Global Pets Anti-infective Drugs Revenue Market Share by Application (2018-2023)
Table 127. Global Pets Anti-infective Drugs Revenue Market Share by Application (2024-2029)
Table 128. Global Pets Anti-infective Drugs Price by Application (2018-2023) & (US$/Unit)
Table 129. Global Pets Anti-infective Drugs Price by Application (2024-2029) & (US$/Unit)
Table 130. Key Raw Materials
Table 131. Raw Materials Key Suppliers
Table 132. Pets Anti-infective Drugs Distributors List
Table 133. Pets Anti-infective Drugs Customers List
Table 134. Pets Anti-infective Drugs Industry Trends
Table 135. Pets Anti-infective Drugs Industry Drivers
Table 136. Pets Anti-infective Drugs Industry Restraints
Table 137. Authors List of This Report
LIST OF FIGURES
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Pets Anti-infective DrugsProduct Picture
Figure 5. Global Pets Anti-infective Drugs Revenue (US$ Million), 2018 VS 2022 VS 2029
Figure 6. Global Pets Anti-infective Drugs Market Size (2018-2029) & (US$ Million)
Figure 7. Global Pets Anti-infective Drugs Sales (2018-2029) & (K Units)
Figure 8. Global Pets Anti-infective Drugs Average Price (US$/Unit) & (2018-2029)
Figure 9. External Use Product Picture
Figure 10. Internal Use Product Picture
Figure 11. Injection Product Picture
Figure 12. Dog Product Picture
Figure 13. Cat Product Picture
Figure 14. Others Product Picture
Figure 15. Global Pets Anti-infective Drugs Revenue Share by Manufacturers in 2022
Figure 16. Global Manufacturers of Pets Anti-infective Drugs, Manufacturing Sites & Headquarters
Figure 17. Global Manufacturers of Pets Anti-infective Drugs, Date of Enter into This Industry
Figure 18. Global Top 5 and 10 Pets Anti-infective Drugs Players Market Share by Revenue in 2022
Figure 19. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 20. Global Pets Anti-infective Drugs Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 21. Global Pets Anti-infective Drugs Sales by Region in 2022
Figure 22. Global Pets Anti-infective Drugs Revenue by Region in 2022
Figure 23. North America Pets Anti-infective Drugs Market Size by Country in 2022
Figure 24. North America Pets Anti-infective Drugs Sales Market Share by Country (2018-2029)
Figure 25. North America Pets Anti-infective Drugs Revenue Market Share by Country (2018-2029)
Figure 26. United States Pets Anti-infective Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. Canada Pets Anti-infective Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. Europe Pets Anti-infective Drugs Market Size by Country in 2022
Figure 29. Europe Pets Anti-infective Drugs Sales Market Share by Country (2018-2029)
Figure 30. Europe Pets Anti-infective Drugs Revenue Market Share by Country (2018-2029)
Figure 31. Germany Pets Anti-infective Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. France Pets Anti-infective Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. U.K. Pets Anti-infective Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Italy Pets Anti-infective Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Russia Pets Anti-infective Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. Asia Pacific Pets Anti-infective Drugs Market Size by Country in 2022
Figure 37. Asia Pacific Pets Anti-infective Drugs Sales Market Share by Country (2018-2029)
Figure 38. Asia Pacific Pets Anti-infective Drugs Revenue Market Share by Country (2018-2029)
Figure 39. China Pets Anti-infective Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Japan Pets Anti-infective Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. South Korea Pets Anti-infective Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. India Pets Anti-infective Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Australia Pets Anti-infective Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. China Taiwan Pets Anti-infective Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Indonesia Pets Anti-infective Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Thailand Pets Anti-infective Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Malaysia Pets Anti-infective Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Latin America Pets Anti-infective Drugs Market Size by Country in 2022
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Pets Anti-infective DrugsProduct Picture
Figure 5. Global Pets Anti-infective Drugs Revenue (US$ Million), 2018 VS 2022 VS 2029
Figure 6. Global Pets Anti-infective Drugs Market Size (2018-2029) & (US$ Million)
Figure 7. Global Pets Anti-infective Drugs Sales (2018-2029) & (K Units)
Figure 8. Global Pets Anti-infective Drugs Average Price (US$/Unit) & (2018-2029)
Figure 9. External Use Product Picture
Figure 10. Internal Use Product Picture
Figure 11. Injection Product Picture
Figure 12. Dog Product Picture
Figure 13. Cat Product Picture
Figure 14. Others Product Picture
Figure 15. Global Pets Anti-infective Drugs Revenue Share by Manufacturers in 2022
Figure 16. Global Manufacturers of Pets Anti-infective Drugs, Manufacturing Sites & Headquarters
Figure 17. Global Manufacturers of Pets Anti-infective Drugs, Date of Enter into This Industry
Figure 18. Global Top 5 and 10 Pets Anti-infective Drugs Players Market Share by Revenue in 2022
Figure 19. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 20. Global Pets Anti-infective Drugs Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 21. Global Pets Anti-infective Drugs Sales by Region in 2022
Figure 22. Global Pets Anti-infective Drugs Revenue by Region in 2022
Figure 23. North America Pets Anti-infective Drugs Market Size by Country in 2022
Figure 24. North America Pets Anti-infective Drugs Sales Market Share by Country (2018-2029)
Figure 25. North America Pets Anti-infective Drugs Revenue Market Share by Country (2018-2029)
Figure 26. United States Pets Anti-infective Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. Canada Pets Anti-infective Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. Europe Pets Anti-infective Drugs Market Size by Country in 2022
Figure 29. Europe Pets Anti-infective Drugs Sales Market Share by Country (2018-2029)
Figure 30. Europe Pets Anti-infective Drugs Revenue Market Share by Country (2018-2029)
Figure 31. Germany Pets Anti-infective Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. France Pets Anti-infective Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. U.K. Pets Anti-infective Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Italy Pets Anti-infective Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Russia Pets Anti-infective Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. Asia Pacific Pets Anti-infective Drugs Market Size by Country in 2022
Figure 37. Asia Pacific Pets Anti-infective Drugs Sales Market Share by Country (2018-2029)
Figure 38. Asia Pacific Pets Anti-infective Drugs Revenue Market Share by Country (2018-2029)
Figure 39. China Pets Anti-infective Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Japan Pets Anti-infective Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. South Korea Pets Anti-infective Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. India Pets Anti-infective Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Australia Pets Anti-infective Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. China Taiwan Pets Anti-infective Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Indonesia Pets Anti-infective Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Thailand Pets Anti-infective Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Malaysia Pets Anti-infective Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Latin America Pets Anti-infective Drugs Market Size by Country in 2022
